- Home
- FVRR vs PALI Comparison
FVRR vs PALI Comparison
Compare FVRR & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FVRR | PALI |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 372.4M | 359.7M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FVRR | PALI |
|---|---|---|
| Price | $9.86 | $1.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $18.43 | $11.29 |
| AVG Volume (30 Days) | 706.0K | ★ 2.4M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.83 | N/A |
| P/E Ratio | $22.05 | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $9.67 | $0.55 |
| 52 Week High | $30.66 | $2.86 |
Technical Indicators
Market Signals| Indicator | FVRR | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 36.91 | 44.36 |
| Support Level | N/A | $1.78 |
| Resistance Level | $11.41 | $2.12 |
| Average True Range (ATR) | 0.47 | 0.14 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 6.56 | 30.10 |
Price Performance
Historical ComparisonAbout FVRR Fiverr International Ltd. no par value
Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.